- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00222391
Influence of Thoracic Epidural Anesthesia on Skin Sympathetic Activity and Heart Rate Variability
January 6, 2009 updated by: University Hospital Muenster
Influence of Thoracic Epidural Anesthesia on Skin Sympathetic Activity and Heart Rate Variability in Surgical Patients
The purpose of the study is to evaluate the impact of epidural anesthesia on sympathetic activity in surgical patients.
The study investigates whether a segmental sympathetic block can be determined and can be correlated to level of the sensoric blockade.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment
40
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Muenster, Germany, D-48149
- Department of Anesthesia and Intensive Care, University Hospital Muenster
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- elective surgery
- combined anesthesia with thoracic epidural anesthesia 8 (Th6-9
- Body-mass-index < 30
Exclusion Criteria:
- Fever, Hypothermia, SIRS
- Microangiopathy
- Neuropathy
- Sensomotoric deficits
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
|---|
|
Hemodynamic parameters
|
Secondary Outcome Measures
Outcome Measure |
|---|
|
Level of sensoric block
|
|
skin temperature
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Henrik Freise, MD, Department of Anesthesiology and Intensive Care, University Hospital Münster
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2004
Primary Completion
December 7, 2022
Study Completion
January 1, 2006
Study Registration Dates
First Submitted
September 20, 2005
First Submitted That Met QC Criteria
September 20, 2005
First Posted (Estimate)
September 22, 2005
Study Record Updates
Last Update Posted (Estimate)
January 7, 2009
Last Update Submitted That Met QC Criteria
January 6, 2009
Last Verified
March 1, 2006
More Information
Terms related to this study
Other Study ID Numbers
- 01-Anast-04
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.